Literature DB >> 22514397

Laboratory diagnosis of Chlamydia pneumoniae infections.

R W Peeling1.   

Abstract

Chlamydia pneumoniae is an important cause of respiratory illness. There is a need for accurate and rapid laboratory diagnostic methods that will lead to improved patient care, appropriate use of antimicrobial therapy and a better understanding of the epidemiology of this emerging pathogen. Culture is highly specific but is technically demanding, expensive, has a long turnaround time and its sensitivity is highly dependent on transport conditions. Antigen detection tests such as enzyme immunoassay and direct fluorescent antibody assay, and molecular detection methods such as the polymerase chain reaction assay, may provide a rapid diagnosis without the requirement for stringent transport conditions. The results of these tests should be interpreted with caution until more thorough evaluation is available. Serology remains the method of choice. The limitations of different serological methods for the laboratory diagnosis of C pneumoniae are discussed.

Entities:  

Keywords:  Chlamydia pneumoniae; Laboratory diagnosis

Year:  1995        PMID: 22514397      PMCID: PMC3327923          DOI: 10.1155/1995/696950

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  32 in total

1.  Outbreak of Chlamydia pneumoniae infection in four farm families.

Authors:  C H Mordhorst; S P Wang; J T Grayston
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis.

Authors:  J V Pether; S P Wang; J T Grayston
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

3.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

4.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

5.  Screening for antibody to Chlamydia pneumoniae by the complement fixation test.

Authors:  K Fonseca; C Kluchka; C M Anand
Journal:  Diagn Microbiol Infect Dis       Date:  1994-04       Impact factor: 2.803

6.  Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture.

Authors:  G S Montalban; P M Roblin; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

7.  Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections.

Authors:  G Ozanne; J Lefebvre
Journal:  Can J Microbiol       Date:  1992-11       Impact factor: 2.419

8.  Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR.

Authors:  C L Hyman; M H Augenbraun; P M Roblin; J Schachter; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

9.  Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.

Authors:  M B Aldous; J T Grayston; S P Wang; H M Foy
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  2 in total

1.  Chlamydia pneumoniae pneumonia: An evolving clinical spectrum.

Authors:  D Megran; R W Peeling; T J Marrie
Journal:  Can J Infect Dis       Date:  1995-07

2.  The Clinical Significance of FilmArray Respiratory Panel in Diagnosing Community-Acquired Pneumonia.

Authors:  Huanzhu Chen; Huilan Weng; Meirui Lin; Ping He; Yazhen Li; Qingdong Xie; Changwen Ke; Xiaoyang Jiao
Journal:  Biomed Res Int       Date:  2017-09-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.